Research study Program year 2019 Source: CMS Open Payments

Rvl-203

Research payments

$115,371

54 payments

Through program year 2019, $115,371 in research payments was reported against Rvl-203, across 54 payments, paid by Osmotica Pharmaceutical Corp..

Paid by: Osmotica Pharmaceutical Corp.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$115,371	54

Breakdown

Who paid Research payments · program year 2019

Osmotica Pharmaceutical Corp. $115,371 54 payments

Who received the money Research payments · program year 2019

Sabal Eye Care Organisation paid for research $11,994 2 payments
R&R Eye Research LLC Organisation paid for research $7,269 4 payments
Rochester Ophthalmological Group Organisation paid for research $6,538 2 payments
North Valley Eye Medical Group Organisation paid for research $6,388 2 payments
Advancing Vision Research LLC Organisation paid for research $6,313 2 payments
North Bay Eye Associates INC Organisation paid for research $6,162 2 payments
Kannarr Eye Care Organisation paid for research $6,031 2 payments
Shettle Eye Research INC Organisation paid for research $5,915 2 payments
Abrams Eye Center Organisation paid for research $5,081 2 payments
South Shore Eye Care Organisation paid for research $5,050 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.